Effect of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Quality of Life in Patients with Peritoneal Mesothelioma

Yasmin M. Ali,Joseph Sweeney,Perry Shen,Konstantinos I. Votanopoulos,Richard P. McQuellon,Katie Duckworth,Kathleen C. Perry,Greg Russell,Edward A. Levine

Effect of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Quality of Life in Patients with Peritoneal Mesothelioma

2019

Yasmin M. Ali
Joseph Sweeney
Perry Shen
Konstantinos I. Votanopoulos
Richard P. McQuellon
Katie Duckworth
Kathleen C. Perry
Greg Russell
Edward A. Levine

Introduction Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) is an accepted treatment for peritoneal mesothelioma. In this study, we evaluated QOL after HIPEC for peritoneal mesothelioma.

Keywords:

Hyperthermic intraperitoneal chemotherapy
Peritoneal mesothelioma
Quality of life
Medicine
Surgery
Prospective cohort study
Brief Pain Inventory
Surgical oncology
General surgery
Center for Epidemiologic Studies Depression Scale
Internal medicine
Cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations